Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment
- PMID: 16634461
- PMCID: PMC10833214
- DOI: 10.1177/153331750602100203
Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment
References
-
- 1. NCA Tracking Sheet for Positron Emission Tomography (FDG) and Other Neuroimaging Devices for Suspected Dementia (CAG- 00088R). Available online at: https://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=104.
-
- 2. Matchar DM, Kulasingam SL, McCrory DC, et al.: Use of positron emission tomography and other neuroimaging techniques in the diagnosis and management of Alzheimer's disease and dementia: Task Order No. 7. Prepared by Duke University under Contract No. 290-97-0014. Rockville, MD: Agency for Health Care Policy and Research, February 2002. Available online at: http.:www.cms.hhs.gov/coveragedownload/id64.pdf.
-
- 3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC; American Psychiatric Association, 1994.
-
- 4. Small GW, Rabins PV, Barry PP, et al.: Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association and the American Geriatrics Society. JAMA. 1997; 278: 1363-1371. - PubMed
-
- 5. McKhann G. Drachman D, Folstein M, et al.: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984; 34: 939-944. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
